Barclays’s Inspire Medical Systems INSP Stock Holding History

Barclays’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-70,400	Closed	-$13.2M	–	4939
2020 Q4	$13.2M	Buy	70,400 +23,700	+51%	+$3.87M	0.01%	1037
2020 Q3	$6.03M	Buy	+46,700	New	+$5.15M	﹤0.01%	1295
2020 Q1	–	Sell	-150,000	Closed	-$11.1M	–	6290
2019 Q4	$11.1M	Sell	150,000 -334,800	-69%	-$21.5M	0.01%	1313
2019 Q3	$29.6M	Buy	484,800 +384,800	+385%	+$25.3M	0.02%	680
2019 Q2	$6.07M	Buy	+100,000	New	+$5.39M	﹤0.01%	1696
2019 Q1	–	Sell	-10,000	Closed	-$423K	–	7154
2018 Q4	$423K	Buy	+10,000	New	+$425K	﹤0.01%	3955

Other funds holding INSP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Barclays's INSP Position: Q2 2026 in Review

Barclays increased its Inspire Medical Systems (INSP) stake by 354% in Q2 2026, buying an estimated $11.4M and bringing the position to 307,270 shares worth $13.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1324.

Barclays first reported a position in INSP in Q2 2018 and has held it in 33 quarters since. The position peaked at $15.9M in Q3 2023. 276 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

Barclays held 307,270 shares of Inspire Medical Systems worth $13.7M as of Q2 2026.
Barclays bought 239,629 Inspire Medical Systems shares in Q2 2026, an estimated $11.4M.
Inspire Medical Systems made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1324 holding.
Barclays first reported a position in Inspire Medical Systems in Q2 2018 and has held it in 33 quarters since.
Barclays's Inspire Medical Systems position peaked at $15.9M in Q3 2023.
276 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.